Wearable Technology for Personalised Physical Activity Feedback in Cardiac Patients: a Feasibility Study
Launched by UNIVERSITY OF BATH · Oct 31, 2022
Trial Information
Current as of August 19, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is exploring how wearable technology can help heart patients stay active and engaged in their recovery after a heart event, like a heart attack. The study aims to see if a six-week program using a wrist-mounted activity monitor, along with a digital platform and remote support, can encourage patients who have either declined or dropped out of traditional cardiac rehabilitation (CR) programs to get back on track. The goal is to make physical activity more accessible and personalized, helping patients understand their progress and encouraging them to follow health guidelines.
To participate in this study, individuals should be aged between 65 and 74, have a history of heart conditions like heart attacks or heart failure, and must have access to a smartphone or tablet with the internet. They should also have declined or dropped out of CR in the past year. Participants can expect to receive support through technology that helps them manage their physical activity in a way that fits their individual needs. This study is important because it aims to find new ways to improve participation in cardiac rehabilitation, which could significantly benefit heart patients and reduce healthcare costs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria: Patients will be recruited in line with British Association for Cardiovascular Prevention and Rehabilitation (BACPR) guidelines, which states that the following priority patient groups shall be offered CR irrespective of age, sex, ethnic group, and clinical condition:
- • Acute coronary syndrome
- • Coronary revascularisation
- • Heart failure
- Other patient groups known to benefit:
- • Stable angina
- • Peripheral arterial disease
- • Post-cerebrovascular event
- • Post-implantation of cardiac defibrillators and resynchronisation devices
- • Post-heart valve repair/replacement
- • Post-heart transplantation and ventricular assist devices
- • Adult congenital heart disease
- Participants must also:
- • Have access to a smart phone or tablet and the internet
- • Have declined or dropped out of CR in the last 12 months
- • Exclusion Criteria: Patients who were not referred/deemed eligible for CR (assessed by clinical care team)
- • No access to the internet and/or a smart phone
- • Individuals who have completed CR in the last 12 months
- • Unable to read English
- • Unable to understand written or verbal information
About University Of Bath
The University of Bath is a leading UK institution recognized for its commitment to academic excellence and innovative research. With a strong focus on health and well-being, the university conducts clinical trials that aim to advance medical knowledge and improve patient outcomes. Leveraging a multidisciplinary approach, the University of Bath collaborates with various stakeholders, including healthcare professionals and industry partners, to ensure the integrity and efficacy of its research initiatives. Through its state-of-the-art facilities and expertise, the university is dedicated to contributing valuable insights to the scientific community and enhancing the quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bath, , United Kingdom
Patients applied
Trial Officials
Oliver Peacock, PhD
Principal Investigator
University of Bath
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials